Although these studies were based on low sample numbers, many authors assumed that p53 alterations do not play a role in the “serrated route” of intestinal tumorigenesis (Jass, 2007), thereby contrasting classic colorectal cancer development. The gene discussed is TP53; the disease is colorectal cancer.